Multinational companies in China’s vaccine market face headwinds amid an anti-corruption crackdown and rising competition.

HONG KONG, LONDON] Ever since AstraZeneca shocked investors in October with news its China chief was under investigation, the ...

X’s director of engineering, Haofei Wang, has suddenly left the company, according to sources with knowledge of the matter.

The investments come amid an ongoing investment fraud probe into AstraZeneca’s former China head Leon Wang—and despite ...

The tech-heavy Nasdaq Composite index recently entered correction territory. Though it was able to climb out of it, equities ...

British pharmaceutical giant AstraZeneca on Friday announced plans to invest $2.5 billion in China, despite the detention ...

AstraZeneca said on Friday it will spend Ksh.323 billion on a research and development hub in Beijing, as the drugmaker ...

The largest of the collaborations is a potentially more than $4.68 billion partnership with Shanghai-based Harbour BioMed to ...

BEIJING] AstraZeneca will invest US$2.5 billion in a new research centre in Beijing, in a major show of commitment to China ...

AstraZeneca (AZN) said Friday it plans to invest $2.5 billion in a new research and development hub in China as the drugmaker tries to reignite ...

Tallying up a wide range of investments, AstraZeneca said it is pumping $2.5 billion into Beijing. The figure includes ...

AstraZeneca Plc will invest $2.5 billion in a new research center in Beijing, in a major show of commitment to China just ...